In vitro Competitors binding experiments verified that MAM-2201 and AM-2201 possess nanomolar affinity for equally CD-one murine and human CB1 and CB2 receptors, with preference for that CB1 receptor. In agreement Together with the in vitro binding information, in vivo studies showed that MAM-2201 induces Visible, acoustic, and tactile impairments https://fernandohaodr.blogprodesign.com/52873652/detailed-notes-on-eam-2201